Antje Willuweit

2.3k total citations
74 papers, 1.7k citations indexed

About

Antje Willuweit is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Antje Willuweit has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Physiology and 16 papers in Genetics. Recurrent topics in Antje Willuweit's work include Alzheimer's disease research and treatments (20 papers), Glioma Diagnosis and Treatment (14 papers) and Amino Acid Enzymes and Metabolism (9 papers). Antje Willuweit is often cited by papers focused on Alzheimer's disease research and treatments (20 papers), Glioma Diagnosis and Treatment (14 papers) and Amino Acid Enzymes and Metabolism (9 papers). Antje Willuweit collaborates with scholars based in Germany, United States and Netherlands. Antje Willuweit's co-authors include Karl‐Josef Langen, Matthias Clauss, N. Jon Shah, Dieter Willbold, Janine Kutzsche, Philipp Lohmann, Carina Stegmayr, Norbert Galldiks, Christian Filß and Gabriele Stoffels and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Nature Neuroscience.

In The Last Decade

Antje Willuweit

71 papers receiving 1.7k citations

Peers

Countries citing papers authored by Antje Willuweit

Since Specialization

Citations

This map shows the geographic impact of Antje Willuweit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Willuweit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Willuweit more than expected).

Fields of papers citing papers by Antje Willuweit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Willuweit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Willuweit. The network helps show where Antje Willuweit may publish in the future.

Co-authorship network of co-authors of Antje Willuweit

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Willuweit. A scholar is included among the top collaborators of Antje Willuweit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Willuweit. Antje Willuweit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intraretinal Electrophysiology and Resistivity Profiles of WT and RCS Rat Retina 2025 ·Sensors ·(unknown), Antje Willuweit, (unknown)	0
2	An orally available Ca_v2.2 calcium channel inhibitor for the treatment of neuropathic pain 2023 ·British Journal of Pharmacology ·Janine Kutzsche, (unknown), Antje Willuweit, Olaf Kletke, (unknown), (unknown), Dagmar Jürgens, Jörg Breitkreutz, Holger Stark, Annette G. Beck‐Sickinger, Nikolaj Klöcker, Patricia Hidalgo, Dieter Willbold	7
3	Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives 2023 ·Cancers ·Karl‐Josef Langen, Norbert Galldiks, Jörg Mauler, Martin Köcher, Christian Filß, Gabriele Stoffels, (unknown), Carina Stegmayr, Antje Willuweit, (unknown), N. Jon Shah, Christoph Lerche, Felix M. Mottaghy, Philipp Lohmann	6
4	Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease 2023 ·Nature Neuroscience ·(unknown), (unknown), Lothar Gremer, (unknown), Benedikt Frieg, Luisa U. Schäfer, Antje Willuweit, L Donner, Margitta Elvers, Lars Nilsson, Stina Syvänen, Dag Sehlin, Martin Ingelsson, Dieter Willbold, Gunnar F. Schröder	30
5	ClC-3 regulates the excitability of nociceptive neurons and is involved in inflammatory processes within the spinal sensory pathway 2022 ·Frontiers in Cellular Neuroscience ·(unknown), Antje Willuweit, (unknown), (unknown), (unknown), (unknown), Frank Müller, Angelika Lampert, Christoph Fahlke, Raul E. Guzman	4
6	Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy 2022 ·Neurochemistry International ·(unknown), (unknown), Antje Willuweit, Janine Kutzsche, Jeannine Mohrlüder, Dieter Willbold	9
7	A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model 2021 ·Molecules ·(unknown), (unknown), (unknown), Philipp Lohmann, N. Jon Shah, Karl‐Josef Langen, Dieter Willbold, Antje Willuweit, Janine Kutzsche	7
8	PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), N. Jon Shah, Karl‐Josef Langen, Dieter Willbold, Janine Kutzsche, (unknown), Antje Willuweit	4
9	Sex-Related Motor Deficits in the Tau-P301L Mouse Model 2021 ·Biomedicines ·(unknown), (unknown), Robert Bauer, N. Jon Shah, Karl‐Josef Langen, Dieter Willbold, Janine Kutzsche, Antje Willuweit, (unknown)	6
10	Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2 2018 ·Neurobiology of Disease ·(unknown), (unknown), (unknown), Christian Zafiu, Tamar Ziehm, Karl‐Josef Langen, N. Jon Shah, Janine Kutzsche, Antje Willuweit, Dieter Willbold	12
11	Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's disease 2017 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), Tamar Ziehm, (unknown), Nan Jiang, Markus Tusche, N. Jon Shah, Karl‐Josef Langen, Janine Kutzsche, Dieter Willbold, Antje Willuweit	11
12	The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology 2017 ·Scientific Reports ·Thomas van Groen, (unknown), Oleksandr Brener, Lothar Gremer, Tamar Ziehm, Markus Tusche, Luitgard Nagel‐Steger, Inga Kadish, (unknown), (unknown), Dagmar Jürgens, Antje Willuweit, Janine Kutzsche, Dieter Willbold	47
13	Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d -enantiomeric peptide 2016 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Nan Jiang, (unknown), (unknown), Thomas van Groen, Inga Kadish, N. Jon Shah, Karl‐Josef Langen, Dieter Willbold, Antje Willuweit	24
14	Pharmacokinetic properties of tandem d-peptides designed for treatment of Alzheimer's disease 2016 ·European Journal of Pharmaceutical Sciences ·(unknown), Nan Jiang, (unknown), (unknown), (unknown), Tamar Ziehm, Janine Kutzsche, N. Jon Shah, Jörg Breitkreutz, Karl‐Josef Langen, Antje Willuweit, Dieter Willbold	23
15	Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease 2015 ·PLoS ONE ·Nan Jiang, (unknown), (unknown), Tamar Ziehm, Jörg Mauler, Lothar Gremer, (unknown), (unknown), N. Jon Shah, Janine Kutzsche, Karl‐Josef Langen, Jörg Breitkreutz, Dieter Willbold, Antje Willuweit	39
16	Effects of Spatial and Cognitive Enrichment on Activity Pattern and Learning Performance in Three Strains of Mice in the IntelliMaze 2011 ·Behavior Genetics ·Alina Codita, Abdul H. Mohammed, Antje Willuweit, (unknown), Enrico Alleva, Igor Branchi, Francesca Cirulli, Giovanni Colacicco, Vootele Võikar, David P Wolfer, (unknown), Hans‐Peter Lipp, Elisabetta Vannoni, Sven Krackow	27
17	Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage 2010 ·Genes Brain & Behavior ·Sven Krackow, Elisabetta Vannoni, Alina Codita, A.H. Mohammed, Francesca Cirulli, Igor Branchi, Enrico Alleva, (unknown), Antje Willuweit, Vootele Võikar, Giovanni Colacicco, David P Wolfer, J. Buschmann, Kamran Safi, Hans‐Peter Lipp	114
18	Continuous Endothelial Cell Activation Increases Angiogenesis: Evidence for the Direct Role of Endothelium Linking Angiogenesis and Inflammation 2006 ·Journal of Vascular Research ·Rajashekhar Gangaraju, Antje Willuweit, Carolyn E. Patterson, (unknown), Andreas Hilbig, Georg Breier, Armin Helisch, Matthias Clauss	61
19	Tumor necrosis factor signaling not important for arteriogenesis but for angiogenesis 2003 ·Journal of the American College of Cardiology ·Armin Helisch, Shawn Wagner, Antje Willuweit, Wulf Ito, Matthias Clauss, Wolfgang Schäper	1
20	Chronic Inflammation and Protection from Acute Hepatitis in Transgenic Mice Expressing TNF in Endothelial Cells 2001 ·The Journal of Immunology ·Antje Willuweit, Gabriele Sass, (unknown), Ulrich Eisel, Gisa Tiegs, Matthias Clauss	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact